Cardiopulmonary Exercise Testing Option to Innocor
510(k) K071911
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK071911 | Date7 Sep 2007 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DQK
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.1425
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The Cardiopulmonary Exercise Testing Option to Innocor is a device designed for non-invasive measurement of respiratory parameters during exercise. It functions as an add-on module to the Innocor system, enabling breath-by-breath analysis of respiratory flow and gas concentrations. This option supports the assessment of metabolic parameters, including oxygen uptake and carbon dioxide production, during cardiopulmonary exercise testing. It is classified under product code DQK and is intended for use in clinical settings where hemodynamic and metabolic monitoring are required.
This device is supplied as part of the Innocor system and is used in conjunction with a pneumotachometer placed between a respiratory valve and the patient. It is intended for single-use or reusable applications, depending on the manufacturer’s guidelines, though sterility and reuse instructions are not specified in the data. The device has been cleared by the FDA under 510(k) number K071911, demonstrating substantial equivalence to the predicate device Medical Graphics Ultima System. No specific MRI safety or storage requirements are mentioned in the provided data.
Other devices from Innovision A/S
Questions
AI-generated answers, 1 Oct 2026
What is the Cardiopulmonary Exercise Testing Option to Innocor used for?
This module is designed to enable non-invasive measurement of respiratory parameters during exercise testing. It attaches to the Innocor system and provides breath-by-breath analysis of respiratory flow and gas concentrations (oxygen uptake and carbon dioxide production). Clinicians use it to assess metabolic responses during cardiopulmonary exercise testing, particularly in settings requiring hemodynamic and metabolic monitoring.
How is the Cardiopulmonary Exercise Testing Option to Innocor supplied and used?
The device is supplied as an add-on module for the Innocor system. It requires a pneumotachometer placed between a respiratory valve and the patient to function. The module itself is intended for single-use or reusable applications, though specific sterility or reuse guidelines must be followed as per Innovision’s instructions.
Is this device approved for MRI environments?
The provided data does not mention MRI safety or compatibility for this device. If MRI use is required, additional verification or documentation from Innovision A/S should be consulted to ensure safe operation.
What regulatory approval does this device hold?
The Cardiopulmonary Exercise Testing Option to Innocor has been cleared by the FDA under 510(k) number K071911, demonstrating substantial equivalence to the Medical Graphics Ultima System. This clearance is specific to its intended use in cardiopulmonary exercise testing.
Are there specific storage requirements for this module?
The data does not specify any particular storage requirements for the Cardiopulmonary Exercise Testing Option to Innocor. However, standard environmental controls (e.g., temperature, humidity) for medical devices should be followed to maintain functionality and integrity until use.